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Abstract Biology-oriented-synthesis (BIOS), is a chemocentric ap-
proach to identifying structurally novel molecules as tools for chemical
biology and medicinal chemistry research. The vast chemical space can-
not be exhaustively covered by synthetic chemistry. Thus, methods
which reveal biologically relevant portions of chemical space are of high
value. Guided by structural conservation in the evolution of both pro-
teins and natural products, BIOS classifies bioactive compound classes
in a hierarchical manner based on molecular architecture and bioactivi-
ty. Biologically relevant scaffolds inspire and guide the synthesis of BIOS
libraries, which calls for the development of suitable synthetic method-
ologies. These compound collections have enriched biological rele-
vance, leading to the discovery of bioactive small molecules. These po-
tent and selective modulators allow the study of complex biological
pathways and may serve as starting points for drug discovery pro-
grams. Thus, BIOS can also be regarded as a hypothesis-generating
tool, guiding the design and preparation of novel, bioactive molecular
scaffolds. This review elaborates the principles of BIOS and highlights
selected examples of their application, which have in turn created fu-
ture opportunities for the expansion of BIOS and its combination with
fragment-based compound discovery for the identification of biologi-
cally relevant small molecules with unprecedented molecular scaffolds.
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1 Introduction
Small molecules are excellent tools for chemical biology
research and the analysis of complex biological mecha-
nisms. Their effect is acute, yet not permanent and can be
tuned, e.g., by dosage, to work reversibly and rapidly,1 in
contrast to most genetic approaches. Thus, the develop-
ment of selective small molecule as probes for protein tar-
gets is of high value for studying and understanding biolog-
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space may accommodate ca. 1060 small molecules,2 render-
ing its investigation by means of synthesis alone an unfeasi-
ble task.
On the other end of the scale, nature has circumvented
this issue by conserving the structural and chemical prop-
erties of protein-binding sites during their selection and
evolution. There are more than 10390 combinations possible
for a protein of an average size of 300 amino acids, synthe-
sized from 20 different amino acids.2 However, an estimat-
ed 25,000 proteins may be encoded even in the complicated
human genome, containing subdomains that are conserved
within protein classes. This restriction may be attributed to
thermodynamic stability rather than function, which im-
poses physical and chemical evolutionary pressure on pro-
tein formation.3,4 The arrangement of secondary structures
(α helices and β sheets) determines the three-dimensional
structure of proteins, which leads to the formation of char-
acteristic fold classes of the individual protein domains.
These folds determine the size and shape of binding sites
for ligands or substrates, whilst the chemical structure of
amino acid residue side chains determines the kind of li-
gand (e.g., polar, nonpolar) that can be bound. Additionally,
these ligand-accommodating sites within single domain
proteins can be represented by about 1300 binding pock-
ets.3 This fact suggests that a given fold type may be formed
by different amino acid sequences and thus even protein
domains with low primary sequence homology can have
very similar folds.5
In direct analogy, natural products (NPs) have a limited
number of core scaffolds, which are distinguished by differ-
ent groups decorating the central scaffold. NPs are small-
molecule secondary metabolites and have been a major
source of inspiration for chemists and chemical biologists.6
NPs are intrinsically different from compounds resulting
from conventional combinatorial synthesis, due to their in-
creased three-dimensional character, which also correlates
with higher success rates in drug discovery projects.7 NPs
have evolved to interact with more than one protein, as
they are typically formed through sequential binding of
biosynthetic intermediates to different enzymes and also
display different biological effects, either within the pro-
ducing organism or across different species.8 The diverse
substitution patterns in NPs of related molecular scaffolds
result in different bioactivity profiles, suggesting that NPs
define evolutionary selected structures, which can interact
with multiple proteins, whilst selectivity is finely tuned by
the functional groups of each individual molecule. NPs de-
fine biologically relevant portions of vast chemical space.
These principles can be applied in the design and prepa-
ration of novel small molecules which modulate the func-
tion and activity of proteins. NP molecular scaffolds can be
analyzed to identify the relevant features for bioactivity and
subsequently applied to the synthesis of NP-inspired com-
pound libraries with simplified, more synthetically attain-
able structures. Systematic and structure-based approach-
es, which can serve as the basis and guide the development
of small molecules with novel bioactivities, are of high val-
ue in chemical biology and medicinal chemistry research.
Biology-oriented synthesis (BIOS) is based on the structural
analyses of NPs and their respective protein targets and
abides to the evolutionary conservatism and functional-
group diversity principles encountered in nature. Develop-
ing collections of NP-inspired compounds with diverse sub-
stitution patterns around a common core scaffold may re-
sult in matching the diversity of amino acid side chains oc-
curring within otherwise similar protein subfolds. Thus,
BIOS is a chemocentric approach taking advantage of
prevalidated, biologically relevant starting points offered by
NP structure. The resulting compound collections are en-
riched in bioactivity and can be used for the development
of molecular tools for the study of protein function and to
decipher complex biological phenomena.
2 Structural Classification of Natural Prod-
ucts
To chart the chemical space covered by NPs, a chemoin-
formatic tool termed ‘structural classification of natural
products’ (SCONP) was developed.9 By using SCONP, the
highly complex NP structures can be reduced, by classifying
and arranging the core scaffolds in a hierarchical manner,
resulting in the generation of a branch for each scaffold. In
each branch, each parent scaffold is a substructure of its
offspring and branches merge together to generate a scaf-
fold tree (Figure 1). Initially, the chemical space covered by
natural products contained gaps where certain substruc-
tures had not been discovered yet or had not emerged
through nature’s evolutionary process. Virtual scaffolds
were thus generated in silico, derived from the iterative de-
construction process itself. These scaffolds have not yet
been reported and they provide excellent starting points for
the syntheses of NP-inspired compounds.
Moving along the branches of the scaffold tree, starting
from the outer, more complex structures to the inner, struc-
turally more simplified scaffolds is a process termed ‘bra-
chiation’. This linear movement along the branches of a
scaffold tree suggests that the bioactivity encoded in the
derived substructures is partially retained, e.g., potency
may be lowered, and proceeds with the retention of biolog-
ical relevance. This principle is analogous to fragment-
based drug discovery,10 and is based on the assumption that
smaller scaffolds may transfer their biologically relevant
characteristics to the resulting molecules into which they
are incorporated. As such, scaffold trees may be alternative-
ly constructed on the basis of bioactivity instead of chemi-
cal structure.11 These biology-guided scaffold trees offer
different perspectives of chemical space by using bioactivi-Georg Thieme Verlag  Stuttgart · New York — Synthesis 2019, 51, 55–66
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lecular scaffolds in which a particular kind of bioactivity is
retained.
3 Implications and Opportunities for Biolo-
gy-Oriented Synthesis
BIOS can be applied through SCONP to identify un-
known, biologically relevant regions of chemical space. As
bioactivity is guiding the selection of scaffolds, the result-
ing compound collections may be enriched in bioactivity,
which in turn  suggests that the size of the compound col-
lections to be synthesized can be reduced. This principle
compensates for the fact that the preparation of these com-
pounds may be more elaborate compared to combinatorial
libraries. Additionally, NP-inspired compounds may be less
structurally complex when compared to the guiding NPs,
resulting in reliable and efficient synthetic routes and re-
tained bioactivity. Ultimately, BIOS aims to provide com-
pounds which can be used to develop optimized structures
based on a biologically relevant scaffold. This optimization
can be achieved through established approaches and strate-
gies of medicinal chemistry and may improve the potency
or physicochemical properties of selected candidates de-
pending on their intended use as lead for drug development
Figure 1  The classification of NP core scaffolds into a ‘scaffold tree’ as calculated by the SCONP algorithm
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on the continuous development of novel and robust chemi-
cal methods that can be subsequently applied in the paral-
lel preparation of compound collections with structurally
complex scaffolds in a modular manner.
Preparing structurally simplified scaffolds, by following
the BIOS process, may lead to the resulting molecules en-
gaging multiple protein targets with similarly shaped li-
gand-binding sites. This potential promiscuity can be re-
garded as an advantage, as biological networks are often re-
dundantly interconnected, suggesting that several
modulating interactions are necessary for the desired bio-
logical effect. NPs have been selected and evolved for their
ability to interact in a dynamic manner with such systems
and these properties can be passed down to NP-inspired
compounds through their chemical structures. Any selec-
tivity issue which may arise can be addressed through es-
tablished medicinal chemistry approaches, suggesting that
BIOS offers unique opportunities for the preparation of
molecules which may display poly-bioactivity profiles, and
as such can be proven ideal tools for systems biology re-
search (Scheme 1). To take full advantage of these poly-bio-
active compounds, target-agnostic and cell-based pheno-
typic screenings can be undertaken; it is essential that
these are coupled with effective strategies for target decon-
volution, identification, and validation.8 Finally, the BIOS
principles can be applied to non-natural-derived bioactive
scaffolds and compound classes, as the approach is guided
by the biological relevance itself and not its occurrence in
nature.
4 Applications of Biology-Oriented Synthesis
The principles of BIOS can be applied to guide the de-
sign and preparation of NP-inspired molecular scaffolds
employing different aspects of NPs as the guiding principle.
For example, following the chemical structure of the core
scaffold as the guiding principle may result in a distinct bio-
logically relevant compound class compared to when utiliz-
ing bioactivity as a guiding principle. Employing these as-
pects in a complementary manner can result in the effi-
cient preparation of biologically enhanced compound
libraries and can lead to the discovery of structurally un-
precedented bioactive small molecules.
4.1 Chemical Structure and Bioactivity Guided 
Approaches
Polycyclic scaffolds with a high degree of three-dimen-
sionality can be prepared by the utilization of chemical cas-
cade reactions. These scaffolds are useful synthetic tools to
investigate the hypotheses generated by the application of
the SCONP algorithm and the scaffold tree. Due to their
modularity, cascade reactions facilitate the preparation of
compound collections that are large enough for the applica-
tion of BIOS, as the resulting scaffolds are already biologi-
cally relevant. Cascade reactions producing polycyclic scaf-
folds or fusing fragments require the use of structurally
simple starting materials, in reduced quantities as well as in
fewer handling and purification steps. As an example, a
twelve-step reaction cascade sequence, including nine dis-
crete chemical transformations,13 was used in the prepara-
tion of the structurally complex tetracyclic tetrahydroin-
doloquinolizines (Scheme 2, A). This scaffold resembles a
Scheme 1  BIOS overview. NPs are used to select simplified scaffolds 
that guide the preparation of compound libraries with enriched bioac-
tivities, leading to the identification of novel small molecule modula-
tors, which may be used as tools in chemical biology research.
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classification
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G. Karageorgis, H. Waldmann Short ReviewSyn thesisnumber of polycyclic indole alkaloid structures.14 This cas-
cade was further utilized to prepare a focused compound
collection, which was screened for mitosis modulation, as
previously reported indole-alkaloid-based molecules were
reported to affect this process.15,16 Arrested mitosis and
multipolar mitotic spindles were observed using confocal
microscopy imaging of recombinant cells, revealing at least
two compounds with low micromolar effective concentra-
tions. The centrosomal protein NPM1, which is a centro-
some duplication regulator,17 and its associated nuclear ex-
port factor Crm118 were identified as the biological targets
through a chemical proteomics investigation using activity-
based pull-down probes followed by MS determination or
immunoblotting. Further evidence of target engagement
was demonstrated by using knockdown cell lines. These
novel inhibitors were used to guide the design of a focused
structurally simplified collection, prepared by a newly de-
veloped enantioselective synthetic route (Scheme 2, B).19
Subsequent screening for mitosis modulation led to the
identification of an analogue with a fourfold increased po-
tency. This finding provided further evidence that BIOS can
be applied in non-naturally occurring yet biologically rele-
vant molecules as well.
Alternative, yet complementary to linear cascades,
branching reaction cascades are highly efficient synthesis
tools, which can be used for the preparation of diverse mo-
lecular scaffolds using only a few common precursors.20 In-
tra- or intermolecular reactions can be used, involving a
number of complexity generating branching cascades re-
sulting in the formation of diverse and complex molecular
architectures in a rapid and concise manner.21 Thus,
branching cascades are fitting tools for the preparation of
compound collections guided by BIOS. For example, a range
of bi-nucleophilic reagents were used with a common
starting material bearing multiple electrophilic positions.
Their reaction resulted in the formation of twelve discrete
and structurally diverse unprecedented molecular scaffolds
(Scheme 3), some of which were NP-related.22
Iridoids are a class of structurally complex NPs, which
have been reported to exhibit neuroprotective or neurite-
growth-promoting properties.23,24 The BIOS approach was
applied to the iridoid scaffold in order to develop small
molecules aimed at the study and treatment of neurode-
generative diseases.25–27 A sequence involving a [3+2] cyclo-
addition and a regioselective Baeyer–Villiger oxidation gave
Scheme 2  Cascade reactions are ideal for the application of BIOS. A) A structurally complex polycyclic scaffold was prepared by using a twelve-step 
reaction cascade. B) An enantioselective reaction was developed to prepare structurally simplified analogues resulting in the identification of mitosis 
modulators with up to a four-fold increase in potency.
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G. Karageorgis, H. Waldmann Short ReviewSyn thesisaccess to two molecular scaffolds of the general iridoid class
(Scheme 4).28 Subsequent development of an enantioselec-
tive route, followed by individual scaffold derivatization
steps, led to the preparation of a collection of 54 molecules
This collection was screened for activity by using a primary
hippocampal neuron outgrowth assay and a mouse embry-
onic stem cell motor neuron growth assay, leading to the
identification of novel active compounds with neurite-
growth-promoting properties. These compounds displayed
different patterns of neurite growth promotion and may be
used as biological tools to investigate these neurodevelop-
mental processes further.
Scheme 4  Irridoid-inspired design and preparation of a neurite-
growth-promoting compound class: A. examples of iridoid NPs; B. 
chemical synthesis of iridoid scaffold analogues and related molecules; 
C. compounds that display neurite growth properties.
Similarly, secoyohimbane NPs (Scheme 5) have also
been reported to possess neurite-growth-promoting prop-
erties.29–31 Their core scaffold is characterized by a high de-
gree of three-dimensionality and consists of four connected
rings and a spiral center. The development of an organocat-
alytic, enantioselective synthetic route towards secoyohim-
bane analogues gave access to a collection of 56 com-
pounds. Although structurally simplified compared to the
guiding NPs, five of these compounds exhibited neurite-
growth-promoting properties when using either the hippo-
campal neurite outgrowth or the mouse embryonic stem
cell motor neurite growth assays.32 These findings provided
further validation for BIOS as a chemocentric hypothesis-
generating approach, which can lead to the identification of
bioactive small molecules.
4.2 Natural-Product-Derived Fragment-Based 
Approaches
Fragments are molecules with low molecular weight33
that have been shown to expedite the exploration of chemi-
cal space.34 Earlier attempts at fragment-based drug discov-
ery10 utilized compound libraries where the fragments are
derived from known drugs, covering already known por-
tions of chemical space35,36 and including a low number of
molecular structures with a high degree of three-dimen-
sionality.37
Natural products are characterized by a high degree of
three-dimensional character. Furthermore, they occupy bi-
ologically relevant portions of chemical space that are often
not covered by synthetically accessible compounds,38 as
NPs are biologically prevalidated by nature. Additionally,
NP-derived fragments may display different biologically rel-
evant profiles compared to synthetically accessible frag-
ments, as suggested by the chemoinformatic analyses of
natural product structures based on fragment likeness.39,40
Suitable NP-derived fragments can be selected by the
SCONP algorithm using additional filtering algorithms. A
virtual set of NP-derived fragments was shown to have a
high degree of three-dimensional character, structural
complexity, and diversity, and occupied different portions
of chemical space compared to a set of commercially avail-
able fragments.41 Additionally, their distribution of physical
properties was found to be similar to that of the guiding
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G. Karageorgis, H. Waldmann Short ReviewSyn thesisNPs. Thus, NP-derived fragments can be used to identify
compounds with unprecedented chemotypes, which act as
modulators of known biological targets. For example, deriv-
atives of the structurally complex, bicyclic cytisine–
sparteine scaffold were found to be allosteric inhibitors of
the p38a MAP kinase (Figure 2).41 These findings suggested
that the BIOS principles can be expanded to include NP-
derived fragments as simplified substructures of NPs, with
applications in fragment-based ligand discovery. These
fragments are synthetically more tractable when compared
to the guiding NPs, which may require multistep proce-
dures for their preparation. Thus, compound libraries com-
prised  of NP-derived fragments can be used to overcome
limitations associated with synthetic tractability of certain
NPs and efficient methodologies for the preparation of such
fragments are in high demand.
Molecular scaffolds which include NP-derived frag-
ments may result in compound collections with limited
structural diversity, due to their predefined structures. To
overcome this potential limitation, a common starting ma-
terial can be used that combines an embedded NP fragment
with orthogonally reactive functional groups. These groups
can undergo different chemical transformations when
treated with different catalysts or reagents and afford struc-
turally diverse compounds which include NP-derived frag-
ments in their molecular scaffolds. Versatile chemical
methodologies which have the potential to proceed via
multiple divergent reaction pathways are needed for the
successful application of this approach. These reagent-
directed syntheses can give access to compound collections
with enhanced structural complexity and diversity as well
as additional biological relevance instilled by the incorpora-
tion of the NP-derived fragment.
The oxindole fragment forms part of a number of di-
verse NPs exhibiting different bioactivities42,43 and is also
incorporated in a number of compounds included in medic-
inal chemistry and drug discovery projects.44,45 Harnessing
the versatility of gold-catalyzed reactions, a common oxin-
dole-derived 1,6-enyne starting material was used to give
rise to three distinct molecular scaffolds with NP features
(Scheme 6, A). The regio-reactivity of the enyne functional-
ity was modulated by the source of gold and the properties
of the ligand used in each case,42,46,47 allowing the orthogo-
nal preparation of each scaffold on demand leading to the
divergent formation of a skeletally diverse collection of 60
compounds. In order to investigate the biological relevance
and potential activity of these compounds, cellular assays
monitoring biological pathways, rather than individual tar-
gets, were employed.
The Hedgehog (Hh) pathway is a conserved signaling
pathway involved in a number of processes such as cell pro-
liferation and differentiation and tissue regeneration and
repair, and has been associated with conditions such as
birth defects and cancer.48 Equally important, the Wnt sig-
naling pathway is implicated in processes such as cell pro-
liferation and migration, tissue regeneration, cell polarity,
as well as stem cell renewal, playing a key role in the prolif-
eration of malignant tissue.49 Autophagy is a catabolic pro-
cess playing an integral part in cell homeostasis. This pro-
cess involves the self-degradation of cellular components
such as damaged organelles and denatured proteins, and is
thought to act as a survival mechanism for cancer cells un-
dergoing metabolic stress caused by a lack of nutrients or
oxygen and increased energy demand. Inhibition of the au-
tophagy process has recently emerged as a potential strate-
gy for targeting cancer.50 By utilizing cellular assays that
monitor these processes, structurally unprecedented and
selective inhibitors of the Hedgehog and Wnt signaling
pathways, the autophagy process, as well as cellular prolif-
eration were revealed. Two compounds displayed low mi-
cromolar inhibitory activity of the Hh pathway, yet did not
interfere with cell viability (Scheme 6, B). Additional bio-
logical characterization demonstrated that these com-
pounds act as reversible binders of the transmembrane pro-
tein Smoothened (Smo), which is an activator of the Hh
pathway. A different oxindole-derived compound was
shown to have low micromolar inhibitory activity against
the Wnt pathway. This selective and structurally novel in-
hibitor did not interfere with the Hh pathway (Scheme 6,
B). A structurally distinct compound was revealed to inhibit
the autophagy process selectively. Additionally, a novel can-
cer cell proliferation modulator was also identified by using
an imaging assay which monitors cell confluency. This
structurally distinct compound did not exhibit any activity
in the Hh and Wnt or autophagy assays.
Following a different synthetic approach and working
towards the application of these principles, an asymmetric
1,3-dipolar cycloaddition of azomethine ylides with various
Figure 2  Natural-product-derived fragments identified as novel inhibi-
tors of the p38a MAP kinase: A) examples of two different fragment 
classes; B) crystal structure of the p38a MAP kinase with a fragment 
bound at the allosteric site of the protein (PDB: 4EH9).Georg Thieme Verlag  Stuttgart · New York — Synthesis 2019, 51, 55–66
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with a bicyclic scaffold containing the pyrrolizidine frag-
ment.51 This NP-derived fragment is encountered in com-
pounds with bioactivities ranging from insecticides to car-
cinogens and other alkaloid NPs.52,53 Employing glutamate-
derived imines and maleimide derivatives in the presence
of a chiral copper–ferrocene catalyst complex, followed by
an intramolecular lactamization, this new synthetic meth-
odology gave access to a collection of 30 compounds. Se-
lected compounds of this collection exhibited antibacterial
activity, inhibiting the growth of the pathogen P. falciparum
whilst others were revealed to act as Hedgehog pathway in-
hibitors with activities in the low micromolar range
(Scheme 6, B). These findings demonstrate that synthetic
approaches which incorporate NP-derived fragments can
be applied to prepare biologically relevant compound col-
lections. These distinct and structurally diverse small mole-
cules may act as selective modulators of different biological
processes and signaling pathways, with direct applications
in chemical biology research.
The preparation of compound libraries with molecular
scaffolds that have only certain common fragments, yet do
not share the whole core scaffold with the guiding NPs, may
still lead to the identification of biologically relevant small
molecules. This observation suggests that novel molecular
scaffolds may inherit the physiochemical and bioactive
properties of NPs, if they incorporate combinations of NP-
derived fragments. These combinations may give rise to
novel chemical matter that is biologically relevant, but not
linked to specific biological targets. Thus, the resulting
Scheme 6  NP-derived fragments may enhance biological relevance when embedded in molecular scaffolds. A) Scaffold-divergent synthesis led to the 
identification of skeletally different compounds from a common starting material, with diverse bioactivities. B) The enantioselective preparation of 
scaffolds containing pyrrolizidine fragments resulted in the identification of compounds with antibacterial properties.
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G. Karageorgis, H. Waldmann Short ReviewSyn thesischemotypes can be used to explore portions of chemical
space which cannot be reached by NPs, since such fragment
combinations may not be obtainable through biosynthetic
pathways. Similar to the biological evaluation of newly dis-
covered NPs, these compounds require more elaborate
screening efforts and their potential would be best explored
by the use of target agnostic cellular assays which follow
phenotypic changes rather than individual biological tar-
gets.
These novel NP-derived fragment combinations require
the development of enantioselective synthetic methods for
the preparation of enantiopure compounds at will, since
bioactivity is often correlated with the absolute configura-
tion of specific NPs. For example, a hybrid scaffold with
eight stereocenters, combining the tropane and pyrrolidine
fragments, was accessed through a catalytic enantioselec-
tive cycloaddition in an enantiodivergent fashion.54 The tro-
pane fragment has been the focus of medicinal chemistry
studies and biological research,55,56 since it is abundantly
encountered in a plethora of alkaloid NPs that exhibit a
range of diverse biological effects.57–59 Similarly, the pyrroli-
dine fragment can be found in a variety of biologically rele-
vant NPs – alkaloids and others – and forms part of ap-
proved drugs as well as research compounds.60 A chiral cop-
per(I)–phosphine catalyst was used to kinetically resolve
the racemic tropane starting material, which reacts with an
azomethine ylide to form this pyrrotropane scaffold. The
unreacted enantiomer of the tropane starting material can
then be converted into a distinct analogue of the pyrrotro-
pane scaffold in the presence of a different azomethine
ylide and a racemic copper(I)–phosphine in a one-pot man-
ner. The two analogues can then be purified via chromatog-
raphy with only one purification step resulting in the isola-
tion of two distinct compounds. Furthermore, reversing the
addition of the two azomethine ylides leads to the forma-
tion of the opposite enantiomers, which can also be ob-
tained on demand (Scheme 7, A). In a different example, the
combination of the tropane and oxindole fragments was
achieved in an enantioselective fashion by utilizing a bime-
tallic relay catalysis approach.61 Oximino-derived cyclic
azomethine ylides reacted with oxindole-bearing olefins
leading to the formation of spiro-tropoxindoles (Scheme 7,
B). This specific fragment combination is precedented in
NPs, which exhibit diverse bioactivities such as antiplasmo-
dials and vasorelaxants.58,62 However, a catalytic enantiose-
lective method for the preparation of this biologically rele-
vant and structurally complex molecular scaffold had not
been reported previously. Such methods provide the oppor-
tunity to explore adjacent portions of chemical space to
those covered by the guiding NPs, through the preparation
of analogues which cannot be obtained through biosynthe-
sis alone.
By extension, non-natural yet NP-inspired scaffolds may
also be prepared by minimal chemical modifications of the
guiding NPs. For example, the use of regioselective ring
contractions or expansions or intramolecular transforma-
tion of functional groups can give access to new molecular
scaffolds from NPs in a direct manner. These compounds
Scheme 7  A) One-pot enantiodivergent synthesis of hybrid NP-derived fragment scaffolds enabled by the kinetic resolution of tropanes with azome-
thine ylides catalyzed by a chiral copper(I)–phosphine complex. B) Enantioselective preparation of spiro-tropoxindoles, by means of bimetallic relay 
catalysis.
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G. Karageorgis, H. Waldmann Short ReviewSyn thesismay retain their biological relevance and properties63,64 and
have the potential to fill in gaps in chemical space that have
remained unexplored by nature. Due to their existing struc-
tural diversity, NPs can be used as the starting materials for
such chemocentric approaches and they can prove to be
ideal substrates for regio- and stereoselective transforma-
tions.65 The application of these principles was demonstrat-
ed by Hergenrother and co-workers, who utilized a ring-
distortion strategy to prepare diverse, structurally complex,
and distinct small molecules directly from guiding NPs in a
rapid manner.66 This strategy allows the capitalization of
NP properties, such as biologically relevant structural fea-
tures, already bestowed by nature.65 In a similar manner, an
oxazatwistane scaffold can be prepared directly from cin-
chona alkaloids via ring distortion. This class of NPs in-
cludes bioactive molecules such as quinine and quinidine
(Figure 3).67 By utilizing late-stage C–H functionalization,
transformations to the resulting oxazatwistane scaffold, as
well as metal-catalyzed coupling reactions allowed the
preparation of a collection of about 50 analogues. These
compounds were subjected to phenotypic and target-
agnostic cellular assays leading to the identification of sub-
micromolar inhibitors of starvation-induced autophagy
(Figure 3). These compounds represent structurally unprec-
edented autophagy modulators68 and their bioactivity  pro-
file is distinct from that of the guiding NPs, as none of qui-
nine, quinidine, or the unsubstituted oxazatwistane scaf-
fold was found to exhibit this inhibitory activity at the
tested concentration.
Figure 3  Cinchona alkaloid natural products such as quinidine can be 
directly transformed into novel scaffolds such as the oxazatwistane. 
Late-stage functionalization enabled the preparation of substituted 
oxazatwistanes, which were identified as submicromolar inhibitors of 
autophagy.
5 Conclusions and Outlook
Small molecules are excellent tools for the study and
elucidation of complex biological mechanisms, as their
mode of action can be conditional, tunable, reversible, and
rapid. Thus, design principles and methodologies facilitat-
ing the charting and qualitative analysis of chemical space
in a systematic manner enable the identification of biologi-
cally relevant chemical matter and unprecedented bioactive
chemotypes. The ‘structural classification of natural prod-
ucts’ (SCONP) algorithm enables the structural analyses of
NP scaffolds, which represent prevalidated and biologically
relevant spots in chemical space. As such, SCONP can be a
hypothesis-forming tool, guiding the design and prepara-
tion of compound libraries which have been demonstrated
to possess enriched bioactivity and give rise to potent and
selective modulators for established biological targets.
These compounds have also been used as tools for chemical
biology research, leading to the identification of novel bio-
logical targets, or may be used as tools for the development
of lead compounds for medicinal chemistry research. While
BIOS collections may contain fewer members, the com-
pounds prepared following BIOS design principles exhibit a
higher degree of three-dimensional character compared to
conventional combinatorial libraries. Furthermore, their
concise syntheses enable the modular modification of func-
tional groups, resulting in sufficient substituent diversity,
which is crucial for the development of specific selectivity
profiles of the corresponding small molecule modulators.
Although additional synthetic effort is required for their
preparation, BIOS collections display higher hit rates com-
pared to combinatorial libraries, due to their enhanced bio-
logical relevance. Evidently, the development and applica-
tion of novel synthetic methodologies granting access to
NP-inspired molecular scaffolds in an efficient and reliable
fashion lie at the core of BIOS, which is a chemocentric ap-
proach for the identification of biologically relevant chemi-
cal matter.
These principles were also applied to fragments that
have been shown to expedite the exploration of chemical
space and are significantly more synthetically tractable.
Specifically NP-derived fragments were included in the
SCONP algorithm, thus expanding the scope of BIOS and
merging this approach with fragment-based compound
discovery. This combination provides an additional tool for
the identification of biologically relevant compounds. The
full potential of these unprecedented molecules can be
demonstrated by the use of unbiased screening methods,
such as cell-based and target-agnostic phenotypic assays, as
demonstrated by the identification of novel and selective
modulators of the Hedgehog and Wnt signaling pathways,
or the autophagy process.
Lastly, BIOS is an approach inspired by the evolutionary
conservation of molecular architectures observed in nature,
and relies on the biological relevance and prevalidation of
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G. Karageorgis, H. Waldmann Short ReviewSyn thesisNPs. BIOS libraries have been shown to have enhanced bio-
logical relevance, leading to the discovery of small molecule
modulators with unprecedented chemotypes with high hit
rates. Therefore, following the BIOS design principles en-
ables overcoming limitations such as synthetic tractability
in the study of NP-inspired compounds and provides new
opportunities for organic synthesis aligned with biological
research.
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